Clinical Trials
11 trialsNCT06048913 2025-07-04
Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Treatment Esophageal Cancer in Old Age
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Completed
NCT01249352 2025-03-31
NICE
Eurofarma Laboratorios S.A.
Phase 2/3 Completed
NCT05278728 2025-02-07
Phase IIa Study of Nimotuzumab to Treat Colorectal Cancer
Biotech Pharmaceutical Co., Ltd.
Phase 1/2 Completed
NCT04207918 2024-05-16
A Phase II Study of Chemoradiotherapy With Nimotuzumab in Unresectable Esophageal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Completed
NCT06363084 2024-04-12
A Retrospective Study for Nimotuzumab Plus Postoperative Adjuvant Chemotherapy for Resectable Pancreatic Cancer
Ruijin Hospital
Completed
NCT02395016 2024-04-04
A Study of Nimotuzumab Combinated With Gemcitabine in K-RAS Wild-type Locally Advanced and Metastatic Pancreatic Cancer
Biotech Pharmaceutical Co., Ltd.
Phase 3 Completed
NCT02591784 2022-03-17
Nimotuzumab in Combination With Radiotherapy for Esophageal Cancer
Biotech Pharmaceutical Co., Ltd.
Phase 2 Completed
NCT01463605 2021-02-04
Nimotuzumab Combined With Radiotherapy for Older Patients With Esophageal Cancer: a Single, Non-control Clinical Trial
ChineseAMS
Phase 2 Completed
NCT00561990 2015-10-15
Nimotuzumab in Adults With Pancreatic Cancer
Oncoscience AG
Phase 2/3 Completed
NCT00950417 2015-08-19
Nimotuzumab in Combination With Chemoradiation for Esophageal Cancer
Biotech Pharmaceutical Co., Ltd.
Phase 1 Completed
NCT02370849 2015-02-25
Cisplatin and S-1 With or Without Nimotuzumab in Untreated Advanced Gastric Adenocarcinoma
ChineseAMS
Phase 2 Completed